Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 21, 2024

SELL
$12.07 - $18.46 $591,430 - $904,540
-49,000 Reduced 40.12%
73,130 $1.08 Million
Q3 2023

Nov 13, 2023

SELL
$18.08 - $23.45 $813,599 - $1.06 Million
-45,000 Reduced 26.93%
122,130 $2.24 Million
Q2 2023

Aug 11, 2023

BUY
$20.98 - $31.42 $3.51 Million - $5.25 Million
167,130 New
167,130 $3.6 Million

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.